News

McKesson To Spin-Off Its Medical-Surgical Solutions Business
McKesson Corporation announced its intention to separate its Medical-Surgical Solutions segment into an independent company.
Former POINT Biopharma CEO, Joe McCann, Joins TAG1 Board of Directors to Advance Isotope Access in Radiopharmaceuticals
TAG1 Inc., a premier supplier of clinical quantities of medical isotopes, today announced the appointment of Joe McCann to ...
Pharm Exec2y
Biopharma Medical Affairs: Where We’ve Been and Where We’re Headed
The importance of medical affairs (medical) in biopharma is growing. To better understand medical’s current challenges and what they mean for the future, Myrto Lee, managing director and partner, ...
Reuters2y
Baxter to divest biopharma business for $4.25 billion
May 8 (Reuters) - Baxter International Inc (BAX.N), opens new tab ... $0.10 per share in the fourth quarter. The medical device maker's biopharma solutions unit supports drugmakers in the ...
Finanznachrichten5mon
Immix Biopharma, Inc.: Immix Biopharma Announces Positive U.S. Clinical Data From First Four Patients in NEXICART-2 U.S. Trial of sterically-optimized CAR-T NXC-201 in relapsed ...
About Immix Biopharma, Inc. Immix Biopharma, Inc. (ImmixBio) (Nasdaq: IMMX) is a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and select immune-mediated ...